Related Experiment Video
Updated: Apr 15, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.5K
Motor neuron disease-frontotemporal dementia: a clinical continuum
Emma Devenney1, Steve Vucic, John R Hodges
1Neuroscience Research Australia, Sydney, NSW, Australia.
Expert Review of Neurotherapeutics
|April 14, 2015
Summary
Motor neuron disease (MND) and frontotemporal dementia (FTD) share clinical, genetic, and pathological links, particularly with the C9orf72 gene expansion. This review explores their overlapping features across the MND-FTD spectrum.
Area of Science:
- Neuroscience
- Neurology
Background:
- Motor neuron disease (MND) and frontotemporal dementia (FTD) exhibit significant overlap at clinical, genetic, and pathological levels.
- The discovery of the C9orf72 genetic expansion has further solidified the connection between MND and FTD.
- MND is increasingly recognized as a multisystem disorder with potential cognitive involvement, sometimes progressing to FTD.
Purpose of the Study:
- To review and clarify the diverse overlapping clinical features observed across the MND-FTD continuum.
- To enhance understanding of the complex relationship between motor neuron degeneration and cognitive decline.
Main Methods:
- Literature review focusing on clinical, genetic, and pathological studies of MND and FTD.
- Analysis of research identifying shared features and diagnostic challenges.
Main Results:
- The C9orf72 expansion is a key genetic link between MND and FTD.
- Cognitive impairment is a common feature in MND, potentially leading to FTD.
- Motor dysfunction can be present in FTD and may be overlooked.
Conclusions:
- Recognizing shared features is crucial for accurate diagnosis and management of patients across the MND-FTD spectrum.
- Further research is needed to fully elucidate the mechanisms underlying the MND-FTD overlap.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia
728
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
728
Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Disorders of the Nervous Tissue
3.2K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.2K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K

